Recommendations

108
Smith et al. 2005
ACC/AHA/SCAI Practice Guidelines
ACC - www.acc.org
AHA - www.americanheart.org
SCAI - www.scai.org
Washington Intracoronary Streptokinase Trial. Circulation
1986;74:703-11.
478. Topol EJ, Califf RM, Vandormael M, et al. A randomized trial of
late reperfusion therapy for acute myocardial infarction:
Thrombolysis and Angioplasty in Myocardial Infarction-6 Study
Group. Circulation 1992;85:2090-9.
479. Dzavik V, Beanlands DS, Davies RF, et al. Effects of late percutaneous
transluminal coronary angioplasty of an occluded infarctrelated
coronary artery on left ventricular function in patients with
a recent (< 6 weeks) Q-wave acute myocardial infarction (Total
Occlusion Post-Myocardial Infarction Intervention Study [TOMI-
IS]—a pilot study). Am J Cardiol 1994;73:856-61.
480. Zeymer U, Uebis R, Vogt A, et al. Randomized comparison of
percutaneous transluminal coronary angioplasty and medical therapy
in stable survivors of acute myocardial infarction with single
vessel disease: a study of the Arbeitsgemeinschaft Leitende
Kardiologische Krankenhausarzte. Circulation 2003;108:1324-8.
481. Horie H, Takahashi M, Minai K, et al. Long-term beneficial effect
of late reperfusion for acute anterior myocardial infarction with
percutaneous transluminal coronary angioplasty. Circulation
1998;98:2377-82.
482. Yousef ZR, Redwood SR, Bucknall CA, Sulke AN, Marber MS.
Late intervention after anterior myocardial infarction: effects on
left ventricular size, function, quality of life, and exercise tolerance:
results of the Open Artery Trial (TOAT Study). J Am Coll
Cardiol 2002;40:869-76.
483. Steg PG, Thuaire C, Himbert D, et al. DECOPI (DEsobstruction
COronaire en Post-Infarctus): a randomized multi-centre trial of
occluded artery angioplasty after acute myocardial infarction. Eur
Heart J 2004;25:2187-94.
484. Kaandorp TA, Bax JJ, Schuijf JD, et al. Head-to-head comparison
between contrast-enhanced magnetic resonance imaging and
dobutamine magnetic resonance imaging in men with ischemic
cardiomyopathy. Am J Cardiol 2004;93:1461-4.
485. Beek AM, Kuhl HP, Bondarenko O, et al. Delayed contrastenhanced
magnetic resonance imaging for the prediction of
regional functional improvement after acute myocardial infarction.
J Am Coll Cardiol 2003;42:895-901.
486. Lima JA. Myocardial viability assessment by contrast-enhanced
magnetic resonance imaging. J Am Coll Cardiol 2003;42:902-4.
487. Sadanandan S, Buller C, Menon V, et al. The late open artery
hypothesis—a decade later. Am Heart J 2001;142:411-21.
488. Barbash GI, Roth A, Hod H, et al. Randomized controlled trial of
late in-hospital angiography and angioplasty versus conservative
management after treatment with recombinant tissue-type plasminogen
activator in acute myocardial infarction. Am J Cardiol
1990;66:538-45.
489. SWIFT trial of delayed elective intervention v conservative treatment
after thrombolysis with anistreplase in acute myocardial
infarction: SWIFT (Should We Intervene Following Thrombolysis?)
Trial Study Group. BMJ 1991;302:555-60.
490. Comparison of invasive and conservative strategies after treatment
with intravenous tissue plasminogen activator in acute
myocardial infarction: results of the thrombolysis in myocardial
infarction (TIMI) phase II trial. The TIMI Study Group. N Engl J
Med 1989;320:618-27.
491. Duber C, Jungbluth A, Rumpelt HJ, Erbel R, Meyer J, Thoenes
W. Morphology of the coronary arteries after combined thrombolysis
and percutaneous transluminal coronary angioplasty for
acute myocardial infarction. Am J Cardiol 1986;58:698-703.
492. Williams DO, Braunwald E, Knatterud G, et al. One-year results
of the Thrombolysis in Myocardial Infarction investigation
(TIMI) Phase II Trial. Circulation 1992;85:533-42.
493. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002
guideline update for the management of patients with unstable
angina and non-ST-segment elevation myocardial infarction--
summary article: a report of the American College of
Cardiology/American Heart Association task force on practice
guidelines (Committee on the Management of Patients With
Unstable Angina). J Am Coll Cardiol 2002;40:1366-74.
494. Fernandez-Aviles F, Alonso JJ, Castro-Beiras A, et al. Routine
invasive strategy within 24 hours of thrombolysis versus
ischaemia-guided conservative approach for acute myocardial
infarction with ST-segment elevation (GRACIA-1): a randomised
controlled trial. Lancet 2004;364:1045-53.
495. Stenestrand U, Wallentin L. Early revascularisation and 1-year
survival in 14-day survivors of acute myocardial infarction: a
prospective cohort study. Lancet 2002;359:1805-11.
496. Alter DA, Tu JV, Austin PC, Naylor CD. Waiting times, revascularization
modality, and outcomes after acute myocardial infarction
at hospitals with and without on-site revascularization facilities
in Canada. J Am Coll Cardiol 2003;42:410-9.
497. Gupta M, Chang WC, Van de WF, et al. International differences
in in-hospital revascularization and outcomes following acute
myocardial infarction: a multilevel analysis of patients in
ASSENT-2. Eur Heart J 2003;24:1640-50.
498. Danchin N, Blanchard D, Steg PG, et al. Impact of prehospital
thrombolysis for acute myocardial infarction on 1-year outcome:
results from the French Nationwide USIC 2000 Registry.
Circulation 2004;110:1909-15.
499. Madsen JK, Grande P, Saunamaki K, et al. Danish multicenter
randomized study of invasive versus conservative treatment in
patients with inducible ischemia after thrombolysis in acute
myocardial infarction (DANAMI). DANish trial in Acute
Myocardial Infarction. Circulation 1997;96:748-55.
500. Ellis SG, Mooney MR, George BS, et al. Randomized trial of late
elective angioplasty versus conservative management for patients
with residual stenoses after thrombolytic treatment of myocardial
infarction. Treatment of Post-Thrombolytic Stenoses (TOPS)
Study Group. Circulation 1992;86:1400-6.
501. Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of
cardiogenic shock and effect of early revascularization on mortality.
Results of an International Registry. SHOCK Registry
Investigators. Circulation 1995;91:873-81.
502. Urban P, Stauffer JC, Bleed D, et al. A randomized evaluation of
early revascularization to treat shock complicating acute myocardial
infarction. The (Swiss) Multicenter Trial of Angioplasty for
Shock-(S)MASH. Eur Heart J 1999;20:1030-8.
503. Hochman JS, Sleeper LA, White HD, et al. One-year survival following
early revascularization for cardiogenic shock. JAMA
2001;285:190-2.
504. Dzavik V, Sleeper LA, Picard MH, et al. Outcome of patients
aged >or= 75 years in the SHould we emergently revascularize
Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do
elderly patients with acute myocardial infarction complicated by
cardiogenic shock respond differently to emergent revascularization?
Am Heart J 2005;149:1128-34.
505. Dauerman HL, Goldberg RJ, Malinski M, Yarzebski J, Lessard D,
Gore JM. Outcomes and early revascularization for patients >or=
65 years of age with cardiogenic shock. Am J Cardiol 2001;87:
844-8.
506. Dauerman HL, Ryan TJ, Jr., Piper WD, et al. Outcomes of percutaneous
coronary intervention among elderly patients in cardiogenic
shock: a multicenter, decade-long experience. J Invasive